APOE and Alzheimer disease: APOE-ε4 has been shown to adversely affect this HDLC-Aβ interaction and has been implicated as a risk factor for cerebral amyloid angiopathy, another prominent pathologic hallmark of AD (Mulder and Terwel, 1998).